GBOKF - Greenbrook TMS Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Greenbrook TMS Inc.

890 Yonge Street
7th Floor
Toronto, ON M4W 3P4

IndustryMedical Care Facilities
Full Time Employees289

Key Executives

NameTitlePayExercisedYear Born
Mr. Bill LeonardPres, CEO & DirectorN/AN/A1965
Mr. Erns LoubserCFO, Treasurer & Corp. Sec.N/AN/AN/A
Mr. Roberto DrassinowerChief Operating OfficerN/AN/A1964
Mr. Geoffrey GrammerChief Medical OfficerN/AN/AN/A
Ms. Euphia Hsu SmithChief Marketing OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Greenbrook TMS Inc. operates outpatient mental health services centers in the United States. The company's Greenbrook centers offer transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy that provides electromagnetic stimulation to brain regions associated with mood regulation for the treatment of major depressive disorders. As of May 10, 2019, it operated 71 company-operated treatment centers in the United States. The company was founded in 2011 and is headquartered in Toronto, Canada.

Corporate Governance

Greenbrook TMS Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.